Literature DB >> 30570753

Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Leidy Y Bastidas-Legarda1, Salim I Khakoo1.   

Abstract

Natural killer (NK) cells are lymphocytes of the innate immune system with essential roles during viral infections. NK cell functions are mediated through a repertoire of non-rearranging inhibitory and activating receptors that interact with major histocompatibility complex (MHC)-peptide complexes on the surface of infected cells. Recent work studying the conserved CD94-NKG2A and variable killer cell immunoglobulin-like receptor-MHC systems suggest that these two receptor families may have subtly different properties in terms of interactions with MHC class I bound peptides, and in recognition of down-regulation of MHC class I. In this review, we discuss how these properties generate diversity in the NK cell response to viruses.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  conserved; natural killer cells; polymorphic; receptor-ligand; viral infection

Mesh:

Substances:

Year:  2019        PMID: 30570753      PMCID: PMC6418463          DOI: 10.1111/imm.13039

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  97 in total

Review 1.  ITAMs versus ITIMs: striking a balance during cell regulation.

Authors:  Daniel D Billadeau; Paul J Leibson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Authors:  Charles L Dulberger; Curtis P McMurtrey; Angelique Hölzemer; Karlynn E Neu; Victor Liu; Adriana M Steinbach; Wilfredo F Garcia-Beltran; Michael Sulak; Bana Jabri; Vincent J Lynch; Marcus Altfeld; William H Hildebrand; Erin J Adams
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

3.  The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells.

Authors:  Collin R Brooks; Tim Elliott; Peter Parham; Salim I Khakoo
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

4.  Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.

Authors:  M Ulbrecht; S Modrow; R Srivastava; P A Peterson; E H Weiss
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

5.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

6.  HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

Authors:  Lena Fadda; Christian Körner; Swati Kumar; Nienke H van Teijlingen; Alicja Piechocka-Trocha; Mary Carrington; Marcus Altfeld
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

7.  Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.

Authors:  Veron Ramsuran; Vivek Naranbhai; Amir Horowitz; Ying Qi; Maureen P Martin; Yuko Yuki; Xiaojiang Gao; Victoria Walker-Sperling; Gregory Q Del Prete; Douglas K Schneider; Jeffrey D Lifson; Jacques Fellay; Steven G Deeks; Jeffrey N Martin; James J Goedert; Steven M Wolinsky; Nelson L Michael; Gregory D Kirk; Susan Buchbinder; David Haas; Thumbi Ndung'u; Philip Goulder; Peter Parham; Bruce D Walker; Jonathan M Carlson; Mary Carrington
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

8.  HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.

Authors:  Jacob Nattermann; Hans Dieter Nischalke; Valesko Hofmeister; Bernd Kupfer; Golo Ahlenstiel; Georg Feldmann; Jiirgen Rockstroh; Elisabeth H Weiss; Tilman Sauerbruch; Ulrich Spengler
Journal:  Antivir Ther       Date:  2005

9.  Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation.

Authors:  Ceri A Fielding; Michael P Weekes; Luis V Nobre; Eva Ruckova; Gavin S Wilkie; Joao A Paulo; Chiwen Chang; Nicolás M Suárez; James A Davies; Robin Antrobus; Richard J Stanton; Rebecca J Aicheler; Hester Nichols; Borek Vojtesek; John Trowsdale; Andrew J Davison; Steven P Gygi; Peter Tomasec; Paul J Lehner; Gavin W G Wilkinson
Journal:  Elife       Date:  2017-02-10       Impact factor: 8.713

10.  Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence.

Authors:  Pavla Strnadova; Hongwei Ren; Robert Valentine; Michela Mazzon; Trevor R Sweeney; Ian Brierley; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2015-09-03       Impact factor: 6.823

View more
  9 in total

1.  The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma.

Authors:  Frazer Warricker; Salim I Khakoo; Matthew D Blunt
Journal:  J Transl Genet Genom       Date:  2021-08-04

2.  The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia.

Authors:  Sudan Tao; Katherine M Kichula; Genelle F Harrison; Ticiana Della Justina Farias; William H Palmer; Laura Ann Leaton; Che Ghazali Norul Hajar; Zulkafli Zefarina; Hisham Atan Edinur; Faming Zhu; Paul J Norman
Journal:  Immunology       Date:  2020-12-20       Impact factor: 7.397

Review 3.  The Neonatal Fc Receptor (FcRn): A Misnomer?

Authors:  Michal Pyzik; Kine M K Sand; Jonathan J Hubbard; Jan Terje Andersen; Inger Sandlie; Richard S Blumberg
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 4.  Involvement of the TRPML Mucolipin Channels in Viral Infections and Anti-viral Innate Immune Responses.

Authors:  Giorgio Santoni; Maria Beatrice Morelli; Consuelo Amantini; Massimo Nabissi; Matteo Santoni; Angela Santoni
Journal:  Front Immunol       Date:  2020-04-29       Impact factor: 7.561

Review 5.  Next generation of immune checkpoint inhibitors and beyond.

Authors:  Julian A Marin-Acevedo; ErinMarie O Kimbrough; Yanyan Lou
Journal:  J Hematol Oncol       Date:  2021-03-19       Impact factor: 17.388

6.  A Detailed View of KIR Haplotype Structures and Gene Families as Provided by a New Motif-Based Multiple Sequence Alignment.

Authors:  David Roe; Cynthia Vierra-Green; Chul-Woo Pyo; Daniel E Geraghty; Stephen R Spellman; Martin Maiers; Rui Kuang
Journal:  Front Immunol       Date:  2020-11-18       Impact factor: 7.561

7.  NKG2C+ natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV.

Authors:  Ting Song; Li Li; Bin Su; Lifeng Liu; Yan Liu; Xiaodong Yang; Qiuyue Zhang; Na Guo; Tong Zhang; Guizhen Sun; Hao Wu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

8.  Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals.

Authors:  Nobuyo Yawata; Mariko Shirane; Kaing Woon; Xinru Lim; Hidenori Tanaka; Yoh-Ichi Kawano; Makoto Yawata; Soon-Phaik Chee; Jay Siak; Koh-Hei Sonoda
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

Review 9.  Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.

Authors:  Katrin Pansy; Barbara Uhl; Jelena Krstic; Marta Szmyra; Karoline Fechter; Ana Santiso; Lea Thüminger; Hildegard Greinix; Julia Kargl; Katharina Prochazka; Julia Feichtinger; Alexander Ja Deutsch
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.